We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Mass screening and treatment (MSaT) for identifying and treating asymptomatic cases of malaria-malaria elimination demonstration project (MEDP), Mandla, Madhya Pradesh

    Background

    Mass screening and treatment (MSaT) aims at reducing the spread of malaria in communities by identifying and treating infected persons...

    Akansha Singh, Harsh Rajvanshi, ... Praveen K. Bharti in Malaria Journal
    Article Open access 27 December 2022
  2. Screening and Clinical Verification of Extracellular Vesicle Biomarkers

    Extracellular vesicles (EVs), lipid bilayer-encapsulated membrane particles carrying proteins, lipids, nucleic acids, and sugars, are shed by most...
    Bo Li, Yiyao Huang, ... Lei Zheng in Extracellular Vesicles
    Chapter 2024
  3. Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial

    Objective

    This study aims to evaluate the feasibility and applicability of an online cervical cancer screening program using a website as the public...

    Yi Zhang, Hui Du, ... Ruifang Wu in Infectious Agents and Cancer
    Article Open access 25 April 2024
  4. Exploring hematopoiesis in zebrafish using forward genetic screening

    Zebrafish have emerged as a powerful animal model for investigating the genetic basis of hematopoiesis. Owing to its close genetic and developmental...

    Hyemin Song, Unbeom Shin, ... Yoonsung Lee in Experimental & Molecular Medicine
    Article Open access 04 January 2024
  5. High-Resolution Mass Spectrometry in Identification of New Analytes & Metabolites

    Numerous forensic institutes including the National Board of Forensic Medicine in Sweden have been using high-resolution mass spectrometry to...
    Svante Vikingsson, Henrik Gréen, Robert Kronstrand in Methods for Novel Psychoactive Substance Analysis
    Protocol 2023
  6. Molecular Dynamics as a Tool for Virtual Ligand Screening

    Rational drug design is essential for new drugs to emerge, especially when the structure of a target protein or nucleic acid is known. To that...
    Grégory Menchon, Laurent Maveyraud, Georges Czaplicki in Computational Drug Discovery and Design
    Protocol 2024
  7. Screening method toward ClbP-specific inhibitors

    Background

    Colibactin is a genotoxin produced by Escherichia coli and other Enterobacteriaceae that is believed to increase the risk of colorectal...

    Tao Zhou, Takayuki Ando, ... Kenji Watanabe in Genes and Environment
    Article Open access 16 February 2023
  8. MALDI-TOF Mass Spectrometry-Based Assay for Measuring Covalent Target Engagement of KRAS G12C Inhibitors

    MALDI-TOF mass spectrometry enables high-throughput screening of covalent fragment libraries and SAR compound progressions of selective KRAS G12C...
    Marcin Dyba, John-Paul Denson, Anna E. Maciag in KRAS
    Protocol 2024
  9. Genomic newborn screening for rare diseases

    Rare diseases are a leading cause of infant mortality and lifelong disability. To improve outcomes, timely diagnosis and effective treatments are...

    Zornitza Stark, Richard H. Scott in Nature Reviews Genetics
    Article 29 June 2023
  10. A retrospective analysis of MS/MS screening for IEM in high-risk areas

    Inborn errors of metabolism (IEM) can lead to severe motor and neurological developmental disorders and even disability and death in children due to...

    **ao He, Juan Kuang, ... Xuekai Shi in BMC Medical Genomics
    Article Open access 16 March 2023
  11. Colorectal cancer screening: results from the World Trade Center Health Registry cohort

    Purpose

    Little is known about colorectal cancer screening in 9/11 World Trade Center (WTC)-exposed populations. We utilized survey data from the WTC...

    Hannah M. Thompson, Janette Yung, ... James Cone in Cancer Causes & Control
    Article 21 June 2024
  12. Mass spectrometric profiling of tryptic digests of trifluoroethanol extracts from core needle biopsies of breast cancer tissues is a viable sample screening tool for biomarker discovery

    Application of classifying limited sampling biopsies by matrix-assisted laser desorption/ionization time-of-flight (MALDI-ToF) based mass spectral...

    Prarthana Gopinath, Gopal Gopisetty, ... Rajkumar Thangarajan in Journal of Proteins and Proteomics
    Article 26 February 2022
  13. Screening for Antibody Specificity and Sensitivity with ELISA

    Monoclonal antibodies (MAbs) can be used to detect and quantify protein biomarker antigens (Ag). Systematic screening with an enzyme-linked...
    Michael J. Halat, Emily Gravens in ELISA
    Protocol 2023
  14. Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes

    Background

    People with severe mental illness (SMI) are 2.5 times more likely to die prematurely from cancer in England. Lower participation in...

    Robert Stephen Kerrison, Alex Jones, ... Cam Lugton in British Journal of Cancer
    Article Open access 04 May 2023
  15. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery

    Develo** safe and effective nanoparticles for the delivery of messenger RNA (mRNA) is slow and expensive, partly due to the lack of predictive...

    Luke H. Rhym, Rajith S. Manan, ... Daniel G. Anderson in Nature Biomedical Engineering
    Article 01 May 2023
  16. Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies

    Prenatal cell-free DNA (cfDNA) screening uses extracellular fetal DNA circulating in the peripheral blood of pregnant women to detect prevalent fetal...

    **glan Zhang, Yanting Wu, ... Hefeng Huang in Nature Medicine
    Article 22 January 2024
  17. Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging

    Cardiac magnetic resonance imaging (CMR) is the gold standard for cardiac function assessment and plays a crucial role in diagnosing cardiovascular...

    Yan-Ran (Joyce) Wang, Kai Yang, ... Shihua Zhao in Nature Medicine
    Article Open access 13 May 2024
  18. Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?

    Background

    In the United Kingdom (UK), cancer screening invitations are based on general practice (GP) registrations. We hypothesize that GP...

    Bhautesh Dinesh Jani, Michael K. Sullivan, ... Frank M. Sullivan in British Journal of Cancer
    Article Open access 25 October 2023
  19. An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    Heart failure with preserved ejection fraction (HFpEF) is under-recognized in clinical practice. Although a previously developed risk score, termed H 2 ...

    Yogesh N. V. Reddy, Rickey E. Carter, ... Barry A. Borlaug in Nature Medicine
    Article 12 July 2024
Did you find what you were looking for? Share feedback.